pyridostigmine bromide has been researched along with lactic acid in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Metzger, DL; Rogol, AD; Thompson, DL; Veldhuis, JD; Weltman, A; Weltman, JY | 1 |
Beitner, R; Chen-Zion, M; Glass-Marmor, L | 1 |
de Vries, WR; Dieguez, C; Klok, LJ; Koppeschaar, HP; Mallo, F; Nooitgedagt, A; Sidorowicz, A | 1 |
Tan, QY; Wu, JY; Xu, ML; Yin, HF; Zhang, JQ | 1 |
Jiang, R; Li, S; Liu, G; Tan, Q; Xu, M; Zhang, J | 1 |
1 trial(s) available for pyridostigmine bromide and lactic acid
Article | Year |
---|---|
Influence of endogenous cholinergic tone and growth hormone-releasing peptide-6 on exercise induced growth hormone release.
Topics: Adult; Cholinesterase Inhibitors; Exercise; Growth Hormone; Growth Hormone-Releasing Hormone; Hematocrit; Humans; Lactic Acid; Male; Oligopeptides; Pyridostigmine Bromide; Random Allocation | 1997 |
4 other study(ies) available for pyridostigmine bromide and lactic acid
Article | Year |
---|---|
Cholinergic and opioid involvement in release of growth hormone during exercise and recovery.
Topics: Adult; Blood Glucose; Endorphins; Exercise; Growth Hormone; Humans; Lactates; Lactic Acid; Male; Naltrexone; Oxygen Consumption; Parasympathetic Nervous System; Presynaptic Terminals; Pulmonary Gas Exchange; Pyridostigmine Bromide | 1993 |
Effects of carbamylcholine and pyridostigmine on cytoskeleton-bound and cytosolic phosphofructokinase and ATP levels in different rat tissues.
Topics: Adenosine Triphosphate; Animals; Brain; Carbachol; Cytoskeleton; Cytosol; Glycogen; Glycolysis; Heart; Lactic Acid; Muscle, Skeletal; Myocardium; Parasympathomimetics; Phosphofructokinase-1; Pyridostigmine Bromide; Rats | 1996 |
Preparation and characterization of poly(lactic acid) nanoparticles for sustained release of pyridostigmine bromide.
Topics: Algorithms; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Delayed-Action Preparations; Drug Carriers; Electrochemistry; Indicators and Reagents; Lactic Acid; Models, Statistical; Nanoparticles; Particle Size; Polyesters; Polymers; Pyridostigmine Bromide; Reproducibility of Results; Spectrophotometry, Ultraviolet; Spectrum Analysis | 2012 |
Nanosized sustained-release pyridostigmine bromide microcapsules: process optimization and evaluation of characteristics.
Topics: Chemistry, Pharmaceutical; Delayed-Action Preparations; Hydrogen-Ion Concentration; Lactic Acid; Nanocapsules; Particle Size; Polyesters; Polymers; Pyridostigmine Bromide; Reproducibility of Results | 2013 |